Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active... – Monomer contains oxygen
Patent
1997-11-26
2000-07-11
Webman, Edward J.
Drug, bio-affecting and body treating compositions
Solid synthetic organic polymer as designated organic active...
Monomer contains oxygen
528 64, A61K 31795, A61P 3118, C08G 1800
Patent
active
060868643
ABSTRACT:
The oligomers of the present invention are polythioureas having 3 to 50 recurring units derived from aromatic diamines substituted with anionic groups, and having a number average molecular weight of less than 10,000. These oligomers are water-soluble, preferably have a rigid backbone, and are pharmaceutically-acceptable. The oligomers are useful for the treatment and/or diagnosis of AIDS.
REFERENCES:
patent: 2833744 (1958-05-01), Neher
patent: 2868834 (1959-01-01), Neher et al.
patent: 3528949 (1970-09-01), Rutledge
patent: 4073768 (1978-02-01), Mark
patent: 4328244 (1982-05-01), Daniel et al.
patent: 4349568 (1982-09-01), Markey et al.
patent: 4435394 (1984-03-01), Ogata et al.
patent: 4471110 (1984-09-01), Christell
patent: 4604404 (1986-08-01), Munson et al.
patent: 4783446 (1988-11-01), Neushul
patent: 4824916 (1989-04-01), Kershner
patent: 4895660 (1990-01-01), Kershner et al.
patent: 4966894 (1990-10-01), Herr et al.
patent: 5124149 (1992-06-01), Shapiro et al.
patent: 5276182 (1994-01-01), Cardin et al.
Antiviral Research, 18 (1992), "Sulfonic Acid Polymers as a New Class of Human Immunodeficiency Virus Inhibitors", Prem Mohan, et al., pp. 139-150.
R.M. Ottenbrite, ACS Symposium Series #186, pp 205-220 (1982) "The Antitumor and Antiviral Effects of Polycarboxyl-ic Acid Polymers".
G. Odian, Principles of Polymerization, 2d, p. 20-25 (1981).
Ahmed, et al., Antiviral Chemistry & Chemotherapy, (1995) 6(1), 34-42, "Potent Inhibition of Herpes Simplex Virus by MDL101028 a Novel Biphenyl Disulphonic Acid Co-polymer".
Cardin et al., "Stilbene Disulfonic Acids. CD4 Antagonists that Block human immunodeficiency Virus Type-1 Growth at Multiple Stages of the Viral Like Cycle" J. Biol. Chem (1991), 266(20), 13355-63.
Taylor et al, Potent Inhibition of Human Immunodeficiency Virus (HIV) by MDL 101028, a Novel Supphonic Acid Polymer.
Morgan, P.W., "Condensation Polymers: By Interfacial and Solution Methods", Title page Chap.4 (1965).
Berge et al., J Pharm. Sciences 66 (1), p. 1-19.
Komp et al, Chemical Abstracts vol. 110 Abstract No. 33727k (1989).
Cardin Alan D.
Fordyce William A.
Kruper William J.
Mullins Michael J.
Peet Norton P.
Merrell Pharmaceuticals Inc.
The Dow Chemical Co.
Voelk Eric K.
Webman Edward J.
LandOfFree
Pharmaceutical formulations comprising polythiourea and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical formulations comprising polythiourea and methods , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulations comprising polythiourea and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-539148